Patent · US Active

Modulators of the 5-hydroxytryptamine receptor 7 and their method of use

US11319327B2 · kind B2 · utility

4Cited by

0References

12Claims

0Family size

Assignees

Temple University-Of The Commonwealth System of Higher Education · US
Praeventix, LLC · US

Inventors

Daniel J. Canney · Ambler, US
Benjamin E. Blass · Eagleville, US
Kevin M. Blattner · Folsom, US
Douglas A. Pippin · Branford, US

Key dates

Filing date	Sep 9, 2020
Grant date	May 3, 2022
Priority date	—
Expiry date	Sep 9, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F7/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.